United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
487.61
-2.63 (-0.54%)
Sep 4, 2026, 4:00 PM EDT - Market closed
United Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, United Therapeutics stock has a consensus rating of "Buy" and an average price target of $664.33. The average 1-year stock price forecast is 36.24% higher than the current stock price, while the lowest is $515 (+5.62%) and the highest is $725 (+48.68%).
Price Target: $664.33 (+36.24%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 8 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $700 | Buy | Maintains | $700 | +43.56% | Sep 2, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $675 | Buy | Maintains | $675 | +38.43% | Sep 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $677 | Buy | Maintains | $677 | +38.84% | Aug 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $660 | Buy | Maintains | $660 | +35.35% | Aug 6, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $516 → $515 | Hold | Reiterates | $516 → $515 | +5.62% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
3.14B
from 3.18B
Decreased by -1.36%
Revenue Next Year
3.44B
from 3.14B
Increased by 9.63%
EPS This Year
27.57
from 27.86
Decreased by -1.03%
EPS Next Year
30.03
from 27.57
Increased by 8.92%
EPS and Forward PE are based on non-GAAP adjusted numbers.